Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration
Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration
Active, not recruiting · NCT01736592 · Registry updated 2026-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase I/II Follow-up Study of SAR422459 in Patients With Stargardt's Macular Degeneration | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, Hereditary, Stargardt disease, eye disorder, hereditary disease, macular degeneration, retinal degeneration, retinal disorder | Active, not recruiting | Phase 2 | 2026-08-26 | NCT01736592 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Sanofi | 254 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Oregon Health and Science University Site Number : 840001 | Portland | United States | 2 |